Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy. [electronic resource]
Producer: 20030425Description: 219-27 p. digitalISSN:- 0003-3197
- Aged
- Antibiotics, Antineoplastic -- adverse effects
- Antineoplastic Agents -- adverse effects
- Breast Neoplasms -- drug therapy
- Cardiovascular Agents -- therapeutic use
- Diastole -- drug effects
- Female
- Heart -- drug effects
- Humans
- Middle Aged
- Razoxane -- therapeutic use
- Trimetazidine -- pharmacology
- Vasodilator Agents -- pharmacology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.